drugset / Trial / NCT01839214

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis

NCT01839214 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study will examine the safety and efficacy in subjects with mild to moderate ulcerative colitis, as measured by Modified Mayo Score, Modified Baron Score, IBDQ, calprotectin and other assessments.

Timeline

Start
2013-01
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject VB-201 Small molecule 80 mg Oral

Indications